Discover Algeria | Press area | Contact  
English Français
Registration
English Français
business-banner

September 30, 2025 | 4 hours ago

  • More options

    Share on LinkedIn
    Share on Twitter

Pharmaceutical industry: Simplified approval procedures for investors

In Algeria, the Ministry of Pharmaceutical Industry has opted for greater flexibility in the conditions required of economic operators in the sector to encourage investment.

Algeria Invest
Legal Notices | Terms of Services
news-detail

During his visit to El Tarf, Minister of Pharmaceutical Industry, Ouacim Kouidri, announced several measures aimed at facilitating investment in the sector. These include extending the prior approval period for new companies from one year to between two and three years, enabling investors to finalize their administrative procedures.

The ministry has also removed the experience requirement for technical director pharmacists, opening the door to young graduates and simplifying recruitment for companies. These changes meet the expectations of industry stakeholders and aim to stimulate both investment and employment.

Amid strong demand, the pharmaceutical sector signed partnerships worth more than $725 million at the Intra-African Trade Fair (IATF) in Algiers. These agreements will enable the development of new projects and greater openness to external markets.


In Annaba, Kouidri oversaw the launch of a Saidal Group project to produce vaccines for the national program. This project is expected to help reduce the import bill by at least $150 million per year and strengthen national health sovereignty.

September 30, 2025 | algeria-logo

  • More options

    Share on LinkedIn
    Share on Twitter
Subscribe to the economic newsletter